[Retracted] Analysis of the Relationship between Scleritis and T Cell Activation in Patients with Hepatocellular Carcinoma Treated with PD-1 Carrelizumab

Table 1

Percentage difference between Treg cells and Th17 cells (‾x ± s).

Group	Number of Treg cells (%)		Number of Th17 cells (%)		Th17/Treg
	T1	T2	T1	T2	T1	T2
The nonscleral group (n = 105)	4.72 ± 1.19	5.49 ± 0.81	1.59 ± 0.49	1.27 ± 0.39	2.26 ± 0.69	1.12 ± 0.49
Scleritis group (n = 15)	4.68 ± 1.18	6.58 ± 0.78	1.58 ± 0.51	1.03 ± 0.28	2.29 ± 0.71	0.56 ± 0.29
t	−0.122	4.896	−0.074	−2.296	0.157	−4.310
P	0.903	<0.001	0.941	0.023	0.876	<0.001